REMS modification - 1,000s of certified retail pharmacies by mid-July
ESI and MEDCO insurance coverage for tens of millions, plus Now millions of Veterans can access Qsymia at only $9 per month.
print and social media campaigns for Qsymia to consumers starts this fall
For Diabetics - American Association of Clinical Endocrinologists for the first time in corporate FDA-approved anti-obesity medications as recommended therapy. These new algorithms will help the adoption of Qsymia into the everyday practice of primary care physicians.
* Now we know why waiting to ink a deal with Big Pharma was worth waiting for.
ESI, MEDCO & VA have professional boards that review the data on before coverage is approved. Nice to see the validation adding up. With a couple of years time they will be able to boast of many thousands of diabetics able to come off their insulin with the help of Qsymia. Think this stock may have a very big future.
"Well, one of the critical aspects of marketing this product is gaining acceptance by a broad audience of primary care physicians. Obviously for cost reasons, it's not sensible for VIVUS to undertake a broad reach out to primary care physicians. So we are in discussions with large pharmaceutical companies to help with that work."
" We’ve begun discussion with large pharmaceutical companies to explore how we can increase efforts with primary care physicians, which we believe is critical to maximizing the value of Qsymia. As we’ve consistently said, the right time to expand this reach would be upon improved access and coverage, which we now have achieved."
Looks like the boss wants a partner to help design and pay for the direct to consumer advertising coming in the next few months. That would require a deal be made very soon. How much will the stock go up the day they announce a Big Pharma has partnered. Next quarterly report is going to be huge.